Mayya Alexandrovna Dymova

22PUBLICATIONS
45CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Mar 28, 2026
Oncolytic Virus VV-GMCSF-Lact and Human GM-CSF Against GL261 Glioma in Immunocompetent Mice.

Alisa B Ageenko, Natalia S Vasileva, Anna S Chesnokova

|Dec 30, 2025
Drug-Induced Partial Immunosuppression for Preclinical Human Tumor Xenograft Models.

Anton K Gorbushin, Natalia A Luzan, Victoriya D Kakhanova

|Oct 28, 2025
Efficacy of Oncolytic Virus VV-GMCSF-Lact Against Immunocompetent Glioma.

Alisa Ageenko, Natalia Vasileva, Gaukhar Yusubalieva

|Jul 29, 2025
Single-Cell Transcriptomic Changes in Patient-Derived Glioma and U87 Glioblastoma Cell Cultures Infected with the Oncolytic Virus VV-GMCSF-Lact.

Dmitriy V Semenov, Natalia S Vasileva, Maxim E Menyailo

|Nov 27, 2024
Using Computer Modeling and Experimental Methods to Screen for Aptamers That Bind to the VV-GMCSF-LACT Virus.

Maya Dymova, Natalia Vasileva, Daria Malysheva

|Feb 24, 2024
Characterizing Aptamer Interaction with the Oncolytic Virus VV-GMCSF-Lact.

Maya A Dymova, Daria O Malysheva, Victoria K Popova

Pageof 4